시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 기침 시럽 시장 보고서(2025년)
Cough Syrups Global Market Report 2025
상품코드 : 1764293
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,448,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,320,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,193,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

기침 시럽 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 가처분 소득 증가, 약제 제제 기술의 진보 등에 기인한다고 생각됩니다. 예측 기간 중의 주요 동향으로는 제품 개발에 있어서의 인공지능의 통합, 개별화 기침 시럽의 작성, 에코 친화적인 포장 솔루션의 혁신, 디지털 건강 모니터링 툴의 진보, 소아 친화적인 제제의 개발 등을 들 수 있습니다.

호흡기 질환의 유병률 증가는 기침 시럽 시장의 향후 성장을 가속할 것으로 예측됩니다. 감염증에 노출되는 기회가 늘어났기 때문에 신속하고 접근하기 쉽고 효과적인 증상 완화 치료에 대한 수요가 높아지고 있습니다. 상태 관리, 호흡기 진정화, 호흡 개선을 지원합니다. 예를 들어, 2025년 2월 미국 기반의 오픈 액세스 온라인 아카이브 및 배포 서버인 MedRxiv는 호흡기 바이러스 관련 입원 건수가 2024년 12월 말 9.3%에서 2025년 1월 말 9.6%로 증가하여 한 달 만에 3.1% 증가했다고 보고했습니다.

기침 시럽 시장의 주요 기업은 자연적이고 부작용이없는 치료를 선호하는 소비자 증가에 대응하기 위해 허브 기침 시럽과 같은 혁신적인 제제의 개발에 주력하고 있습니다. 숟가락, 생강, 감초 등의 천연 성분을 이용하여 목을 완화시켜 기침을 완화시키는 식물 유래의 액체 치료입니다. 예를 들어, 2024년 8월 사우디아라비아에 본사를 둔 제약 회사인 Avalon Pharma는 성인과 2세 이상 어린이 모두에게 적합한 최초이자 유일한 SFDA 승인 제품인 혁신적인 허브 기침 시럽인 Co-pan을 출시했습니다. Co-pan의 발매는 아발론 파마가 다양한 제품 포트폴리오를 확대하고 호흡기·한약부문에서의 리더십을 강화하는데 전념하고 있음을 강조하는 것으로, 왕국의 헬스케어 산업에서의 지속적인 성장과 혁신 전략에 따른 것입니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 전략

제36장 부록

KTH
영문 목차

영문목차

Cough syrups are liquid medicines used to alleviate coughing and related symptoms caused by colds, allergies, or respiratory infections. They contain active ingredients that either suppress the cough reflex (antitussives), assist in clearing mucus from the airways (expectorants), or reduce throat irritation and congestion.

The main types of cough syrups include expectorants, cough suppressants, antihistamines, and combination formulations. Expectorants are medications that help loosen and clear mucus from the lungs and airways, making it easier to cough up. These products are segmented by age group into pediatric and adult categories, with common ingredients including dextromethorphan, guaifenesin, codeine, and others. Major distribution channels comprise pharmacies, online retailers, supermarkets or hypermarkets, and additional outlets.

The cough syrups market research report is one of a series of new reports from The Business Research Company that provides cough syrups market statistics, including the cough syrups industry global market size, regional shares, competitors with the cough syrups market share, detailed cough syrups market segments, market trends, and opportunities, and any further data you may need to thrive in the cough syrups industry. This cough syrups market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The cough syrups market size has grown strongly in recent years. It will grow from $6.36 billion in 2024 to $6.80 billion in 2025 at a compound annual growth rate (CAGR) of 6.9%. The growth during the historic period can be attributed to the rising incidence of respiratory infections, increased awareness of self-medication, expansion of over-the-counter (OTC) availability, escalating pollution levels, and a growing geriatric population.

The cough syrups market size is expected to see strong growth in the next few years. It will grow to $8.75 billion in 2029 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to the rising demand for natural and herbal formulations, increasing preference for sugar-free and alcohol-free variants, expansion of online retail channels, growing disposable incomes in emerging economies, and advancements in drug formulation technologies. Key trends during the forecast period include the integration of artificial intelligence in product development, creation of personalized cough syrups, innovation in eco-friendly packaging solutions, progress in digital health monitoring tools, and development of pediatric-friendly formulations.

The rising prevalence of respiratory disorders is expected to drive the growth of the cough syrups market moving forward. Respiratory disorders are medical conditions that affect the lungs and other parts of the respiratory system, disrupting normal breathing. This increase is attributed to greater exposure to pollutants, allergens, and infections, which has led to higher demand for fast, accessible, and effective symptom relief treatments. Cough syrups assist in managing respiratory symptoms, soothing the airway, and improving breathing by addressing cough, throat irritation, and mucus congestion. For example, in February 2025, MedRxiv, a U.S.-based open-access online archive and distribution server, reported that hospitalizations related to respiratory viruses rose from 9.3% in late December 2024 to 9.6% in late January 2025, marking a 3.1% increase within one month. Thus, the growing prevalence of respiratory disorders is fueling the expansion of the cough syrups market.

Leading companies in the cough syrups market are focusing on creating innovative formulations, such as herbal cough syrups, to cater to the increasing consumer preference for natural and side-effect-free treatments. Herbal cough syrups are plant-based liquid remedies that utilize natural ingredients like tulsi, ginger, and licorice to soothe the throat and relieve cough without synthetic chemicals. For example, in August 2024, Avalon Pharma, a pharmaceutical company based in Saudi Arabia, launched Co-pan, an innovative herbal cough syrup that is the first and only SFDA-approved product of its kind suitable for both adults and children aged two years and above. This sugar-free and alcohol-free syrup offers proven effectiveness and high tolerability, particularly for pediatric patients, and includes a child-friendly dosing syringe. The launch of Co-pan underscores Avalon Pharma's dedication to expanding its diverse product portfolio and reinforcing its leadership in the respiratory and herbal medicine sectors, aligning with its ongoing growth and innovation strategy within the Kingdom's healthcare industry.

In November 2022, PAI Pharma, a U.S.-based pharmaceutical company, acquired VistaPharma for an undisclosed sum. Through this acquisition, PAI Pharma aims to strengthen its leadership in unit-dose and liquid medicines by expanding its product portfolio and improving its capacity to consistently supply a broad range of pharmaceuticals, especially for hospitals, retail pharmacies, and addiction treatment centers. VistaPharma is an India-based pharmaceutical firm that produces and distributes liquid medications, including cough syrups.

Major players in the cough syrups market are Pfizer Inc., Johnson & Johnson Services Inc., The Procter & Gamble Company, Roche Holding AG, Merck & Co. Inc., Bayer Aktiengesellschaft, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, GlaxoSmithKline plc, Teva Pharmaceutical Industries Limited, Boehringer Ingelheim GmbH, Sun Pharmaceutical Industries Ltd., Perrigo Company plc, Cipla Limited, Glenmark Pharmaceuticals Ltd., Dabur India Limited, Alkem Laboratories Ltd., Prestige Consumer Healthcare Inc., Mankind Pharma Limited, The Himalaya Drug Company, Acella Pharmaceuticals LLC.

North America was the largest region in the cough syrup market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in cough syrups report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the cough syrups market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cough syrups market consists of sales of decongestant syrups, antihistamine-based syrups, and mucolytic syrups. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cough Syrups Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cough syrups market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for cough syrups ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cough syrups market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Cough Syrups Market Characteristics

3. Cough Syrups Market Trends And Strategies

4. Cough Syrups Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Cough Syrups Growth Analysis And Strategic Analysis Framework

6. Cough Syrups Market Segmentation

7. Cough Syrups Market Regional And Country Analysis

8. Asia-Pacific Cough Syrups Market

9. China Cough Syrups Market

10. India Cough Syrups Market

11. Japan Cough Syrups Market

12. Australia Cough Syrups Market

13. Indonesia Cough Syrups Market

14. South Korea Cough Syrups Market

15. Western Europe Cough Syrups Market

16. UK Cough Syrups Market

17. Germany Cough Syrups Market

18. France Cough Syrups Market

19. Italy Cough Syrups Market

20. Spain Cough Syrups Market

21. Eastern Europe Cough Syrups Market

22. Russia Cough Syrups Market

23. North America Cough Syrups Market

24. USA Cough Syrups Market

25. Canada Cough Syrups Market

26. South America Cough Syrups Market

27. Brazil Cough Syrups Market

28. Middle East Cough Syrups Market

29. Africa Cough Syrups Market

30. Cough Syrups Market Competitive Landscape And Company Profiles

31. Cough Syrups Market Other Major And Innovative Companies

32. Global Cough Syrups Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cough Syrups Market

34. Recent Developments In The Cough Syrups Market

35. Cough Syrups Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기